DENNIS LANGER

Profile

First Name

: DENNIS

Middle Name

:

Last Name

: LANGER

Related Companies
Titles
Company Name
Related People
DIRECTOR
DICERNA PHARMACEUTICALS INC
DOUGLAS FAMBROUGH, BRIAN K. HALAK, STEPHEN HOFFMAN, JAMES C. JENSON, PETER KOLCHINSKY, DENNIS H. LANGER, JONATHAN MACQUITTY, DAVID MADDEN
EXECUTIVE OFFICER, DIRECTOR
LIGHT SCIENCES ONCOLOGY INC
EDWARD AVEDISIAN, PETER BISGAARD, JAMES C CHEN, JAMES C. CHEN, TERRY GOULD, S ERIK HAGSTROM, JEFF HIMAWAN, JEFF HIMAWAN, PH.D., DAVID P HOLVECK, DAVID P. HOLVECK, MITCHELL HYMOWITZ, LLEW KELTNER, LLEW KELTNER, M.D. PH.D., LISA KOCH-HULLE, LISA I. KOCH-HULLE, THOMAS LAVIN, ROBERT LITTAUER, ROBERT M LITTAUER, ROBERT M. LITTAUER, MARTIN OLIN, MORTIMER SACKLER, AKBAR SEDDIGH, SY-SHI WANG, CRAIG WATJEN, RICHARD K WHITNEY, FRANK E. YOUNG, FRANK E YOUNG, M.D., PH.D.
DIRECTOR
INNOCOLL HOLDINGS, INC.
COURTNEY CARSON, JAMES CULVERWELL, GORDON DUNN, KENNETH E. HIGGINS, MICHAEL MYERS, WILLIAM O-DONNELL, JOHN O-MEARA, PAUL G. OXHOLM, ROLF D. SCHMIDT, STEVEN A. SHALLCROSS, ANTHONY WILD
DIRECTOR
SANCILIO + COMPANY, INC.
CARLA COX, ALAN DUNTON, ANDREW FOLMER, DAREN GRAHAM, PATRICK GRAY, C. CHAD HARRELL, RODERICK JACKSON, KELLY PERKINS, STEPHAN PORTER, STEPHEN PORTER, FREDERICK SANCILIO, TED STOVER, THORSTEINSSON THORSTEINN, MARTIN ZEIGER
DIRECTOR
ALZHEON, INC.
SUSAN ABUSHAKRA, M.D., MICHAEL ACETI, ADEM ALBAYRAK, MENGHIS BAIRU, FRANKLIN BERGER, ADAM HALE BROCKMAN, CHRISTOPHER NOEL DUNN, NOEL DUNN, NEIL W. FLANZRAICH, JEAN-PIERRE GARNIER, FRANZ HEFTI, JORDAN HELLER, JOHN HEY, JOHN ANTHONY HEY, JOHN HEY, PH.D., DIANE K. JORKASKY, M.D., KEN MACE, KENNETH A. MACE, GREGORY LEON MILLER, SCOTT MINICK, DAVID NIKODEM, DAVID NIKODEM, PH.D., GLENN E. PAULY, AIDAN POWER, MRCPSYCH, GINO SANTINI, MUNEER SATEER, MUNEER SATTER, ROBERT SILVERMAN, JEAN-PIERRE SOMMADOSSI, MARTIN TOLAR, MARTIN TOLAR, M.D., PH.D., MARK VERSAVEL, JEREMY YONGXIN YU
DIRECTOR
SANCILIO PHARMACEUTICALS COMPANY, INC.
ALBERT CAVAGNARO, JOHN CELENTANO, JIM GALE, GEOFFREY GLASS, PATRICK GRAY, OSCAR GROET, TONY LODOVICO, LEANDRA MOLLANAZAR, FREDERICK SANCILIO, THORSTEINN THORSTEINSSON, MARC WOLFF
DIRECTOR
MYRIAD GENETICS INC
LAWRENCE C. BEST, MARK C. CAPONE, HELNER DREISMANN, ALEXANDER FORD, WALTER GILBERT, JOHN T. HENDERSON, GARY A. KING, JERRY S. LANCHBURY, RICHARD MARSH, RALPH L. MCDADE, S. LOUISE PHANSTIEL, RICHARD BRYAN RIGGSBEE, W. LLOYD SANDERS, BERNARD F. TOBIN, MARK VERRATTI
DIRECTOR
QUOIN PHARMACEUTICALS, INC.
DENISE CARTER, DENNIS H. LANGER, PETER LANKAU, NATALIE LEONG, MICHAEL MEYERS
DIRECTOR
NEXEOS DIAGNOSTICS, INC.
JEFF HIMAWAN, JEFFREY HIMAWAN, THERESA MANSI, LOUIS MANZI, CHRISTOPHER MOLINEAUX, NICHOLAS SICILANO, NICHOLAS SICILIANO, STEPHEN TULLMAN
DIRECTOR
BROOKLYN IMMUNOTHERAPEUTICS, INC.
MATTHEW ANGEL, TERRY BATEMAN, JEFF BERG, KENDRA BERGER, BRANT BINDER, JAMES BRISTOL, BARRY CHANDLER, CHARLES CHERINGTON, PETER CICALA, DOROTHY CLARKE, KEVIN D-AMOUR, ERIN S. ENRIGHT, JOSEPH J. FARRICIELLI, JR., HOWARD J. FEDEROFF, GREGORY FIORE, SANDRA GURROLA, ANDREW JACKSON, KENNETH L. KEYMER, VLADIMIR KHUCHUA-EDELMAN, MARY BETH LEWIS, SANJEEV LUTHER, STEVE MITGANG, ERICH MOHR, KIRK NAGAMINE, ELENA RATNER, HEATHER B. REDMAN, JAY SIAL, ROGER SIDHU, NICHOLAS J. SINGER, TONY UPHOFF, RICHARD W. WAGNER, WILLIAM WEXLER, PAUL YANOVER
DIRECTOR
QUOIN PHARMACEUTICALS, LTD.
RUHAMA AVRAHAM, RUTH BEN YAKAR, MICHAEL BERELOWITZ, YUVAL BERMAN, DAVID BRAUN, DENISE CARTER, KASBIAN NURIEL CHIRICH, JOSEPH COOPER, JAMES CULVERWELL, GORDON DUNN, DAVID GROSSMAN, SALLY BRIDGET LAWLOR, EYAL LEIBOVITZ, NATALIE LEONG, MICHAEL MYERS, ABRAHAM NAHMIAS, MICHAEL SEMBER, SHAI YARKONI
DIRECTOR
AVICENNA BIOSCIENCES, INC.
PIETER BURGER, JOHN HAMER, THOMAS KAISER, CHRISTOPHER MELDRUM
DIRECTOR
EMPIRICO INC.
SHANNON BRUSE, BRIAN CAJES, OMRI GOTTESMAN, JOHN HAMER, KOLLURI SWAROOP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-02-17
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2026-02-02 
2025-10-30
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2022-02-17 
2025-10-23
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-10-14 
2024-07-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2024-07-01 
2024-06-06
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2024-05-23 
2024-02-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2023-11-03 
2023-03-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-03-09 
2023-03-22
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2022-02-17 
2023-02-15
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2023-02-14 
2022-12-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-04-15 
2022-10-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2022-02-17 
2022-08-31
D
Link
PHARMACEUTICALS 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
DECLINE TO DISCLOSE 
Equity 
2022-08-23 
2022-03-23
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-03-09 
2021-10-12
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2021-10-01 
2021-04-08
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2021-03-25 
2019-02-12
D/A
Link
BIOTECHNOLOGY 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
DECLINE TO DISCLOSE 
Equity 
2019-02-04 
2019-01-18
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-01-03 
2018-09-05
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-05-25 
2018-01-22
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-01-09 
2017-06-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-05-25 
2016-02-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-02-04 
2014-07-15
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-05-20 
2013-12-23
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2013-12-18 
2013-02-04
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2013-01-22 
2012-12-10
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2012-11-01 
2012-07-26
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2012-06-26 
2012-03-01
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2012-01-24 
2012-03-01
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-02-17 
2012-01-23
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2012-01-10 
2011-06-10
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2011-06-06 
2010-06-28
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2010-06-17